Nooney, Roberts, Hewett & Nowicki’s attorneys are evaluating claims from individuals who took Elmiron and were diagnosed with maculopathy.
Elmiron is a drug for interstitial cystitis (IC), or painful bladder syndrome, that has been prescribed to millions of patients since 1996. In 2015, researchers began to discover a potential link between Elmiron and a serious eye disease known as maculopathy. Even as evidence mounted, Elmiron’s manufacturer, Janssen Pharmaceutical, has failed to warn the public about these risks.
IC patients are commonly prescribed 300 milligram daily doses of the drug. Doctors have been known to prescribe 800 or even 1500 milligrams in more serious cases. Millions are taking a drug that could potentially rob them of their vision, and an untold amount of patients may have already suffered serious health issues.
Up until 2015, the potential risks associated with Elmiron were unknown. In 2015, doctors at Atlanta’s Emory Eye Center encountered an eye condition in six women that they hadn’t seen before. This form of maculopathy didn’t seem to have a cause. Upon further investigation, it was discovered that all six women had been taking Elmiron for years.
Studies released in 2018 and 2019 further support the link between Elmiron and maculopathy. It is still unknown how Elmiron causes this condition.
Despite an increase in evidence, eye disease is still not listed as a possible side effect by the manufacturer. It’s possible that an unfathomable amount of people have already suffered a serious eye injury due to their use of Elmiron, and hundreds of thousands of people are at risk.
If you or a loved one were diagnosed with maculopathy after taking Elmiron, you could be owed compensation for medical costs, pain and suffering, lost wages, and other damages. NRH&N wants to help you get it.
If you took Elmiron and were diagnosed with maculopathy, you should consider taking legal action against the drug’s manufacturer. You might have a case if you meet the following criteria:
No two cases are the same, but people who successfully file drug or medical device lawsuits could recover compensation for some or all of the following damages: